DEVICES AND METHODS FOR ASSISTING VALVE FUNCTION, REPLACING VENOUS VALVES, AND PREDICTING VALVE TREATMENT SUCCESS

• US 20150039079A1
• Filed: 09/17/2012
• Published: 02/05/2015
• Est. Priority Date: 09/16/2011
• Status: Active Grant

• Current Assignee: 3DT Holdings LLC
• Original Assignee: Ghassan Kassab
• Inventors: Kassab, Ghassan S.
• Granted Patent: US 9,872,759 B2
• Time in Patent Office: Days
• US Class Current: 623/1.24
• CPC Class Codes: A61B 17/12013 for use in minimally invasive surgery, e.g. endoscopic surgery
• CPC Class Codes: A61B 2017/00557 inflatable A61B2017/22051 takes precedence
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/2433 using balloon catheter
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2002/068 Modifying the blood flow model, e.g. by diffuser or deflector
• CPC Class Codes: A61F 2240/002 Designing or making customized prostheses

Abstract

Devices and methods for assisting valve function, replacing venous valves, and predicting valve treatment successes. In at least one exemplary embodiment of an endograft body configured for expansion within a luminal organ of the present disclosure, the endograft body comprises (a) a first portion having a proximal end defining a proximal end aperture and a distal end defining a distal end aperture, the first portion configured to increase a velocity of fluid flowing therethrough, (b) a second portion having a second portion proximal end defining a second portion proximal end aperture and a second portion distal end defining a second portion distal end aperture.

Claims

1-30. -30. (canceled)

31. An endograft valve device, comprising:

an endograft body configured for expansion within a luminal organ, the endograft body comprising;

a first portion having a proximal end defining a proximal end aperture and a distal end defining a distal end aperture, the first portion configured to increase a velocity of fluid flowing therethrough;

a second portion having a second portion proximal end defining a second portion proximal end aperture and a second portion distal end defining a second portion distal end aperture, wherein the distal end of the first portion is adjacent to the second portion proximal end; and

a valve portion positioned at or near the second portion proximal end, the valve portion configured to receive the fluid flowing through the distal end aperture of the first portion;

wherein the endograft valve device is sized and shaped to fit within the luminal organ, the size and shape based upon data obtained relative to a flow velocity of blood within a vein of a patient.

32-44. -44. (canceled)

45. An endograft valve device, comprising:

an endograft body configured for expansion within a luminal organ, the endograft body comprising;

a first portion having a proximal end defining a proximal end aperture and a distal end defining a distal end aperture, the first portion configured to increase a velocity of fluid flowing therethrough;

a second portion having a second portion proximal end defining a second portion proximal end aperture and a second portion distal end defining a second portion distal end aperture, wherein the distal end of the first portion is adjacent to the second portion proximal end; and

a valve portion positioned at or near the second portion proximal end, the valve portion configured to receive the fluid flowing through the distal end aperture of the first portion;

wherein the endograft valve device is configured based upon a digital model of a luminal organ of a patient;

wherein the digital model incorporates a vessel geometry input indicative of data obtained relative to a patient'"'"'s venous geometry at a first location; and

wherein the digital model further incorporates a flow velocity input indicative of data obtained relative to a flow velocity of blood within the vein of the patient.

46. The endograft valve device of claim 45, wherein the digital model is configured to generate at least one model output based upon at least the vessel geometry input and the flow velocity input.

47. The endograft valve device of claim 46, wherein the at least one model output indicates whether or not the patient is suitable for a valve procedure.

48. The endograft valve device of claim 45, wherein the digital model further incorporates a valve input indicative of at least one digital valve device.

49. The endograft valve device of claim 48, wherein the digital model is configured to generate at least one model output based upon at least the vessel geometry input, the flow velocity input, and the valve input.

50. The endograft valve device of claim 49, wherein the at least one model output indicates whether or not the patient is suitable for a valve procedure based on one or more characteristics of the valve input.

51. The endograft valve device of claim 49, wherein the one or more characteristics of the valve input is/are selected from the group consisting of a wall stress characteristic, a wall shear stress characteristic, a gradient of wall shear stress characteristic, an oscillatory shear index characteristic, and a leaflet characteristic.

52. The endograft valve device of claim 46, wherein the at least one model output indicates that the patient is suitable for a valve procedure based upon at least the vessel geometry input, the flow velocity input, and the valve input, as compared to at least one threshold parameter.

53. The endograft valve device of claim 52, wherein the at least one threshold parameter is selected from the group consisting of a minimum vessel diameter, a vessel diameter range, a minimum flow velocity, a flow velocity range, a minimum vessel cross-sectional area, a vessel cross-sectional area range, a minimum wall stress parameter, a maximum wall stress parameter, a minimum wall shear stress parameter, a maximum wall shear stress parameter, a minimum gradient of wall shear stress parameter, a maximum gradient of wall shear stress parameter, a minimum oscillatory shear index parameter, a maximum oscillatory shear index parameter, and a leaflet closure parameter.

54. The endograft valve device of claim 52, wherein the at least one threshold parameter is selected from the group consisting of a vessel diameter larger than or approximately 8 mm, a cross-sectional area larger than or approximately 0.5 cm², a flow velocity greater than or approximately 30 ml/min, and a wall shear stress greater than or approximately 5 dynes/cm² and less than or approximately 10 dynes/cm².

55. The endograft valve device of claim 46, wherein the at least one model output indicates that the patient is not suitable for a valve procedure based upon fibrosis within the patient'"'"'s vessel geometry.

56. The endograft valve device of claim 46, wherein the at least one model output indicates that the patient is not suitable for a valve procedure based upon at least the vessel geometry input, the flow velocity input, and the valve input, as compared to at least one threshold parameter.

57. The endograft valve device of claim 56, wherein the at least one threshold parameter is selected from the group consisting of a vessel diameter less than or approximately 8 mm, a cross-sectional area less than or approximately 0.5 cm², a flow velocity less than or approximately 30 ml/min, a flow velocity greater than or approximately 150 ml/min, a wall shear stress less than or approximately 5 dynes/cm², and a wall shear stress greater than or approximately 10 dynes/cm².

58. The endograft valve device of claim 49, wherein the at least one digital valve device includes a configuration of the endograft valve device, and wherein the endograft valve device is selected for implantation into the patient based upon the model output.

97. The endograft valve device of claim 48, wherein the digital model comprises a processor operably coupled to a storage medium, the processor operable to generate the at least one model output, and the storage medium configured to store data relating to the vessel geometry input, the flow velocity input, the valve input, and the at least one model output.

101. The endograft valve device of claim 48, wherein the digital model further incorporates a thrombosis input indicative of a level of thrombosis within the vessel geometry.

102. The endograft valve device of claim 101, wherein the digital model is configured to generate at least one model output based upon at least the vessel geometry input, the flow velocity input, the valve input, and the thrombosis input.

103. The endograft valve device of claim 101, wherein the digital model further incorporates a rheology input indicative of a blood rheology property.

59-84. -84. (canceled)

85. An endograft valve device, comprising:

an endograft body configured for expansion within a luminal organ, the endograft body comprising;

a first portion having a proximal end defining a proximal end aperture and a distal end defining a distal end aperture, the first portion configured to increase a velocity of fluid flowing therethrough;

a second portion having a second portion proximal end defining a second portion proximal end aperture and a second portion distal end defining a second portion distal end aperture, wherein the distal end of the first portion is adjacent to the second portion proximal end; and

a valve portion positioned at or near the second portion proximal end, the valve portion configured to receive the fluid flowing through the distal end aperture of the first portion;

wherein the endograft valve device comprises a component of a valve system, the valve system further comprising a cuff configured to fit around a blood vessel and further configured to periodically compress the blood vessel;

wherein the valve system further comprises a processor operably coupled to the cuff, the processor configured to control a compression rate and a relaxation rate;

wherein when the cuff is positioned around the blood vessel at a second location, operation of the processor causes the cuff to compress the blood vessel and relax compression of the blood vessel, whereby relaxation at the relaxation rate increases a rate of blood flow through the blood vessel at the second location; and

wherein when the endograft valve device is positioned within the blood vessel at a first location and wherein when the cuff is positioned around the blood vessel at the second location, operation of the cuff increases the rate of blood flow through the blood vessel at the first location and the second location.

86-96. -96. (canceled)

98-100. -100. (canceled)

104-135. -135. (canceled)